MARIA THERESA CASTILLO: Open Payments
NPI 1093792616 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 42 payments from 6 companies in 2025. Trend: 2023 $64 · 2024 $710 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $459 |
| Ipsen Biopharmaceuticals, Inc | 18 | $293 |
| Gilead Sciences, Inc. | 9 | $247 |
| Novo Nordisk Inc | 1 | $124 |
| ORPHALAN INC | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: REZDIFFRA, IQIRVO, Wegovy, Livdelzi, CUVRIOR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
